Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SCT-200 by SinoCelltech Group for Colorectal Cancer: Likelihood of Approval
SCT-200 is under clinical development by SinoCelltech Group and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
Data Insights
SCT-200 by SinoCelltech Group for Metastatic Colorectal Cancer: Likelihood of Approval
SCT-200 is under clinical development by SinoCelltech Group and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...